MAKES UP TO 100ml AT 1%: Each 1g jar can be formulated into 100ml of a 1% copper peptide serum, or 33ml of a 3% blend for targeted use
Details American Diabetes Association
This trend reflects a shift toward non-filler-based enhancements
Early-phase samples showed elevated glycolytic intermediatesincluding glucose and lactic acidreflecting high metabolic demand, accompanied by decreased TCA cycle intermediates such as glutamic acid, citric acid, and related carbon-flux metabolites
We studied participants with type 2 diabetes who were already using a stable dose of metformin in order to optimise the translational relevance of our findings
Furthermore, studies indicate its safety for long-term use, highlighting its advantages over other peptides in terms of insulin impact, fat metabolism, and safety